埃索美拉唑饭前吃还是饭后吃

(Nexium) is a second-generation proton pump inhibitor. Its current main indications include the treatment of gastroesophageal reflux disease (GERD) and erosive reflux esophagitis; long-term maintenance treatment to prevent recurrence of cured esophagitis patients; and symptom control of gastroesophageal reflux disease (GERD).

In addition, esomeprazole combined with appropriate antimicrobial therapy eradicates Helicobacter pylori and heals duodenal ulcers associated with Helicobacter pylori infection and prevents the recurrence of peptic ulcers associated with Helicobacter pylori infection.

Esomeprazole (Nexium) is best taken 30 minutes before meals, and its recommended dosage varies for different symptoms. The recommended dose for patients with erosive reflux esophagitis is 40 mg once daily for 4 weeks. For patients whose esophagitis is not cured or whose symptoms persist, a further 4 weeks of treatment is recommended.

For long-term maintenance treatment of cured esophagitis patients to prevent recurrence, the recommended dose of esomeprazole is 20 mg once daily. The recommended dosage for symptom control of GERD is as follows: 20 mg once a day for patients without esophagitis. If symptoms are not controlled after 4 weeks of medication, the patient should undergo further examination. After the symptoms disappear, you only need to take 20 mg orally once a day when needed.

If it is to eradicate Helicobacter pylori, a combination of esomeprazole 20 mg/time, amoxicillin 1g/time, and clarithromycin 500 mg/time is usually used twice a day for 7 days.

(Nexium) has become one of the best-selling drugs in the world once it was launched due to its good effects and low side effects, and it is also called a "blockbuster". At present, esomeprazole has been launched in China, and more and more patients will benefit from the treatment of esomeprazole.

Recommended related hot articles: /newsDetail/79850.html